![](/img/cover-not-exists.png)
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myeloma
Tian, E., Landowski, T. H., Stephens, O. W., Yaccoby, S., Barlogie, B., Shaughnessy, J. D.Volume:
7
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-07-0524
Date:
March, 2008
File:
PDF, 675 KB
english, 2008